67 Key findings of the review were: No controlled trials of microalbuminuria screening

were identified. Assessment of proteinuria by spot protein: creatinine ratio is appropriate for macroalbuminuria (100% sensitivity, 92% specificity).68 However this is not sufficiently sensitive for assessment of microalbuminuria. Previous studies have shown the inherent variability in 24 h AER to be in the range of 40–50%.69 This variability is thought to be related to such factors as posture, activity level, diet and glycaemic control. The variability of overnight AER has been shown to be similar to 24 h collections however, the AER in overnight urine samples is 25% lower compared with 24 h urine samples, and has a lower intra-individual variability.70 Screening tests selleck screening library are designed to maximize true positive results (i.e. high sensitivity) at the expense of performing a greater number of confirmatory tests. Several studies have

examined the relationship between AER and ACR performed on the same timed urine sample,23,71–74 however, only 2 of these took gender into account.23,71 A number of studies have also compared ACR on a spot urine or early morning sample with a timed AER,70,74–77 however, none of these studies were stratified by gender. In these studies timed urine collections were used as the gold standard for comparison. Using the recommended cut-off values, the sensitivities of spot Thalidomide ACR in these studies were ≥88%. However different definitions for microalbuminuria selleck inhibitor on the timed collections (15–30 µg/min) as well as varying definitions for a ‘positive’ ACR level (2.0–4.5 mg/mmol) were used. Because of high intra-individual variability, transient elevations of AER into the microalbuminuric range occur frequently. The 95% CI for a sample with AER of 20 µg/min, assuming a coefficient of variation of 20%, are 12–28 µg/min (one measurement), 14–26 µg/min (two measurements) and 15–25 µg/min (three measurements).78 Therefore, clinical assessment should be

based on at least two measurements taken over 3–6 months. Another option for assessment of albuminuria is the ACR which is usually performed on an early morning urine but can also be performed on a random sample. The use of ACR for assessment of microalbuminuria is easier and less time-consuming for the patient than measurement of AER. ACR measurements are particularly useful for screening purposes and for assessing the effects of treatment. For instance, measurements at every visit can be used to evaluate the albuminuric response separately from the blood pressure response during titration of antihypertensive therapy. Comparisons of ACR to the gold standard AER have been made in several studies. All the studies show satisfactory sensitivity (80–100%) and specificity (81–100%) (see Table A3).